Full-Time

Manager – Bioanalytical Systems & Digital Enablement

Celerion

Celerion

1,001-5,000 employees

Global CRO for early-phase development

No salary listed

Lincoln, NE, USA

In Person

Category
Biology & Biotech
Required Skills
Machine Learning
Requirements
  • Bachelor’s degree in IT, Life Sciences, or related field; advanced degree preferred
  • 8–12+ years of experience in bioanalytical, clinical research, or regulated environments
  • Strong hands-on experience with laboratory systems (LIMS, ELN, CDS)
  • System administration, configuration, and troubleshooting
  • Experience leading system implementations and digital transformation initiatives
  • Deep understanding of GxP compliance, data integrity, and validated systems (CSV)
  • Proven ability to operate in both strategic leadership capacity and hands-on technical execution role
  • Experience working across global teams (US and Europe preferred)
  • Knowledge of data integration, automation, and AI/ML applications in lab environments
  • Strong stakeholder management and cross-functional collaboration skills
Responsibilities
  • Facilitate development and execution of globally aligned system strategy in collaboration with local stakeholders
  • Act as hands-on system owner and administrator, supporting day-to-day operations
  • Facilitate alignment between US and Switzerland laboratories through partnership and shared decision-making
  • Work closely with IT, Operations, QA, site teams and other functions to deliver integrated and practical solutions
  • Serve as global coordinator and working leader, accountable for enabling system performance, supporting project delivery, and day-to-day operational support, while ensuring that key decisions are made collaboratively with relevant stakeholders
  • Manage staff in accordance with the organization's policies and applicable laws, responsibilities including interviewing, hiring, training employees; planning, assigning and directing work; appraising performance; rewarding and disciplining employees; addressing complaints and resolving problems; development and coaching of employees
  • Co-develop the global roadmap for bioanalytical systems and digital platforms with input from site stakeholders and functional partners
  • Establish governance that incorporate local requirements and stakeholder input while promoting standardization, scalability, and compliance across all sites
  • Act as both program lead and execution resource, facilitating alignment and consensus across stakeholders
  • Lead global implementations, upgrades, and migrations with active personal involvement where required and in collaboration with site teams
  • Interface with Celerion support teams and site representatives on implementation and utilization of business systems
  • Support development and coordination of AI initiatives in partnership with operations and site stakeholders
  • Directly administer and maintain laboratory systems (LIMS, ELN, CDS) as needed, in alignment with site requirements and governance processes
  • Manage user access, roles, and permissions in compliance with data integrity requirements and site leadership
  • Monitor system performance, troubleshoot issues, and resolve support tickets, coordinating with local users and support teams
  • Support and/or perform system configuration, upgrades, patching, and integrations, ensuring stakeholder awareness and input where relevant
  • Oversee and contribute to instrument integration and data flow between lab systems, working closely with site teams
  • Maintain system documentation and support audit and inspection readiness
  • Ensure end-to-end data flow and visibility across the bioanalytical lifecycle in collaboration with system owners and site stakeholders
  • Drive integration across systems and platforms, balancing global standards with local operational needs
  • Identify and implement opportunities for automation and efficiency gains in partnership with users and functional teams
  • Facilitate strong alignment between US and Switzerland laboratories through active stakeholder engagement and shared decision-making
  • Act as a key connector between IT, Bioanalytical Operations, QA, and other departments
  • Drive global consistency while incorporating local input and constraints
  • Facilitate communication, prioritization, and execution across regions and functions, ensuring transparency in decision processes
  • Promote adoption of AI, automation, and advanced analytics in collaboration with stakeholders and subject matter experts
  • Evaluate new technologies and manage vendor relationships incorporating cross-functional and site feedback into recommendations
  • Drive continuous improvement in system utilization, throughput, and data quality through joint initiatives with operational teams
  • Ensure compliance with GxP, 21 CFR Part 11, and data integrity requirements in partnership with QA and system stakeholders
  • Support CSV activities and inspection readiness, working closely with QA and site representatives
  • Support audits and provide system documentation and evidence with input from relevant stakeholders
  • Drive user adoption through training and change management in collaboration with site leadership and users
  • Define and implement support models with input from global and local stakeholders
  • Provide leadership and serve as a technical escalation point, while coordinating with relevant teams for resolution and decision-making
Desired Qualifications
  • Advanced degree in IT, Life Sciences, or related field preferred

Celerion is a global contract research organization focused on early-phase drug development. It supports pharmaceutical and biotech clients with trial design, feasibility, project management, clinical and medical monitoring, bioanalytical sciences, and regulatory affairs, all conducted under contract. Its work hinges on metabolite profiling using high-resolution mass spectrometry to inform development decisions. With 40+ years of experience and a global, integrated service network, Celerion aims to help clients bring safe, effective treatments to patients faster by delivering rigorous, timely research.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

N/A

Headquarters

Lincoln, Nebraska

Founded

2010

Your Connections

People at Celerion who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • THL’s majority investment should fund expansion of clinical and bioanalytical capabilities.
  • CLIA certification expands Celerion into higher-complexity diagnostic testing workflows.
  • Industry-fastest startup times strengthen win rates with speed-sensitive pharmaceutical sponsors.

What critics are saying

  • Large CRO rivals can match startup speed and compress Celerion’s pricing power.
  • Biotech funding slowdowns reduce study starts and leave beds underutilized.
  • Any compliance or data-integrity failure would quickly damage sponsor trust and renewals.

What makes Celerion unique

  • 50+ years in early phase research and 6,000+ studies built proven execution.
  • 650+ beds across North America, Europe, and Asia provide unmatched capacity.
  • Labnotes and advanced laboratories support faster, more reliable bioanalytical data.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

4%
PharmiWeb.com
May 7th, 2025
Celerion Launches Enhanced Version Of Labnotes Bioanalytical Data Management Software

LINCOLN, Neb.; May 6, 2025 (Business Wire) – Celerion, a global leader in early clinical research and bioanalytical services, announced the launch of the latest version of Labnotes, its cutting-edge bioanalytical electronic laboratory notebook software elevating data handling and analysis capabilities for sponsors. The latest system enhancements streamline laboratory documentation and improve operational efficiency for users. The updated platform also offers advanced tools for handling and organizing large datasets, ensuring faster processing of reports and optimized database queries

Instrument Business Outlook
May 6th, 2025
Celerion Launches Enhanced Version of Labnotes Bioanalytical Data Management Software

Celerion launches enhanced version of labnotes bioanalytical data Management software.

Business Wire
Jun 5th, 2024
Celerion Honored With Prestigious CRO Leadership Award for Ninth Consecutive Year

Celerion was recognized as a CRO Leader in the quality, capabilities and reliability categories across two groups of respondents (small pharma and combined big and small pharma).

Business Wire
May 7th, 2024
Jo Goodman Joins Celerion as Vice President of Bioanalytical Services

Celerion announced the appointment of Jo Goodman as vice president of bioanalytical services in its Lincoln, Nebraska, laboratory.Post this

Business Wire
May 7th, 2024
Jo Goodman Joins Celerion As Vice President Of Bioanalytical Services

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, a leading clinical research organization, specializing in early clinical research and bioanalytical services, today announced the appointment of Jo Goodman as vice president of bioanalytical services in its Lincoln, Nebraska, laboratory. In her new role, Goodman will oversee the strategic direction and operational performance of the Lincoln bioanalytical laboratory, leveraging her extensive experience in pharmaceutical research and development to drive innovation and design and execute customized bioanalysis for clients’ needs. She will be responsible for delivering on Celerion’s bioanalytical promise of industry-leading science, stringent compliance, and speed of delivery. With over 29 years of experience in the pharmaceutical industry, Goodman brings a wealth of knowledge in regulated GxP and discovery bioanalysis for both in-house and outsourced activities. Prior to joining Celerion, she held positions of increasing responsibility at AstraZeneca, MedImmune, and GlaxoSmithKline. Additionally, Goodman is a recognized thought leader, having recently served as a member of the Expert Working Group (EWG) for ICH M10 Bioanalytical Guidance Development and is active in numerous non-profit industry consortia such as EBF, AAPS, and DMDG